Jaguar Health, Inc. (NASDAQ:JAGX)

BRIEF

published on 04/04/2025 at 22:20, 11 months 21 days ago

Jaguar Health Awards New Employee Inducement Grants

Stock Options Restricted Stock Units Jaguar Health Nasdaq Listing Rule Employee Inducement
PRESS RELEASE

published on 04/04/2025 at 22:15, 11 months 21 days ago

Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Jaguar Health, Inc. grants RSUs and stock options to new employees and outlines vesting terms. Also, provides an overview of the Jaguar Health Family of Companies' focus

Stock Options Jaguar Health RSUs New Employees Vesting Terms
BRIEF

published on 04/01/2025 at 22:20, 11 months 24 days ago

Jaguar Health finalise un financement relais

Obligations Convertibles Placement Privé Jaguar Health Mandats Développement Crofelemer
BRIEF

published on 04/01/2025 at 22:20, 11 months 24 days ago

Jaguar Health Completes Bridge Financing

Private Placement Warrants Jaguar Health Convertible Notes Crofelemer Development
PRESS RELEASE

published on 04/01/2025 at 22:15, 11 months 24 days ago

Jaguar Health Announces Closing of Bridge Financing Priced At-The-Market Under Nasdaq Rules
Jaguar Health, Inc. announces the closing of a private placement, issuing convertible promissory notes and unregistered warrants to selected investors, with gross proceeds of approximately $3.448 million

Private Placement Warrants Fundraising Jaguar Health Convertible Notes
BRIEF

published on 03/31/2025 at 14:05, 11 months 25 days ago

Jaguar Health affiche une croissance de son chiffre d'affaires de 20 % en 2024

Résultats Financiers Jaguar Health Produits Sur Ordonnance Réunion De La FDA Croissance Du Chiffre D'affaires En 2024
BRIEF

published on 03/31/2025 at 14:05, 11 months 25 days ago

Jaguar Health Shows 20% Revenue Growth in 2024

Financial Results Jaguar Health Prescription Products FDA Meeting 2024 Revenue Growth
PRESS RELEASE

published on 03/31/2025 at 14:00, 11 months 25 days ago

Jaguar Health Reports 2024 Financials: 2024 Net Revenue Up Approximately 20% Over 2023
Jaguar Health, Inc. reports a 20% increase in total net revenue for 2024, reaching $11.7 million. Expecting first results in Q2 2025 for crofelemer trials. FDA meeting scheduled for Phase 3 OnTarget trial

Financial Results Jaguar Health Net Revenue FDA Meeting POC Trials
BRIEF

published on 03/28/2025 at 14:05, 11 months 28 days ago

Jaguar Health souligne son soutien vétérinaire à Canalevia-CA1

Canalevia-CA1 Approbation De La FDA Oncologie Vétérinaire Chimiothérapie Canine Traitement Non Antimicrobien
BRIEF

published on 03/28/2025 at 14:05, 11 months 28 days ago

Jaguar Health Highlights Veterinary Support for Canalevia-CA1

FDA Approval Canalevia-CA1 Veterinary Oncology Dog Chemotherapy Non-Antimicrobial Treatment

Published on 03/25/2026 at 19:15, 3 hours 9 minutes ago

Gemina Laboratories Ltd. Announces Delisting from the CSE
Published on 03/25/2026 at 13:30, 8 hours 54 minutes ago

Prince Silver Files NI 43-101 Technical Report for Its Stampede Gap Porphyry Copper-Gold-Molybdenum Project in Nevada
Published on 03/25/2026 at 13:30, 8 hours 54 minutes ago

Triera Biosciences - a Zentek Company - Launches Contract Research Organization Services for Custom Aptamer Discovery, Biosensor Enablement, and Machine-Learning Classification
Published on 03/25/2026 at 13:30, 8 hours 54 minutes ago

Strategic Metals Closes Project Sale
Published on 03/25/2026 at 13:25, 8 hours 59 minutes ago

Predictiv AI Expands Active Deployment of CloudRep.ai Across Healthcare, Retail, Real Estate, Travel and Global Markets

View all ACCESSWIRE

Published on 03/25/2026 at 20:00, 2 hours 23 minutes ago

Piramal Pharma Solutions Commemorates 20th Anniversary at Morpeth Facility with Procurement of Korsch X3 Tablet Press
Published on 03/25/2026 at 19:41, 2 hours 42 minutes ago

EQS-Adhoc: STRATEC POSTS IMPAIRMENTS, REPORTS PRELIMINARY RESULTS FOR 2025, AND OFFERS GUIDANCE FOR 2026
Published on 03/25/2026 at 19:30, 2 hours 53 minutes ago

AIXTRON to expand global footprint with new plant in Malaysia
Published on 03/25/2026 at 19:26, 2 hours 57 minutes ago

EQS-Adhoc: AIXTRON SE to expand global footprint with new plant in Malaysia
Published on 03/25/2026 at 18:40, 3 hours 43 minutes ago

TULKUBASH AND KYZYLTASH MINING ASSETS: DECLARATION FROM A GROUP OF INVESTORS

View all EQS

Published on 03/25/2026 at 18:53, 3 hours 30 minutes ago

CIS - Transfert Contrat de Liquidité Portzamparc - 25.03.2026
Published on 03/25/2026 at 18:53, 3 hours 30 minutes ago

LNA SANTE : 2025 Annual Results
Published on 03/25/2026 at 18:31, 3 hours 52 minutes ago

Strong investment performance and active roll-out of our strategy
Published on 03/25/2026 at 18:31, 3 hours 52 minutes ago

Performance soutenue des Investissements et déploiement actif de la stratégie
Published on 03/25/2026 at 18:06, 4 hours 17 minutes ago

LNA SANTE : Résultats Annuels 2025

View all LES ECHOS COMFI WIRE

News